Bianca A W Hoeben

Summary

Affiliation: Radboud University Nijmegen Medical Centre

Country: The Netherlands

PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors
Bianca A W Hoeben
Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
J Nucl Med 51:1076-83. 2010
Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
Bianca A W Hoeben
Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Int J Cancer 129:870-8. 2011
18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
Bianca A W Hoeben
Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
J Nucl Med 54:532-40. 2013

PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors
Bianca A W Hoeben
Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
J Nucl Med 51:1076-83. 2010
....
Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model
Bianca A W Hoeben
Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Int J Cancer 129:870-8. 2011
..i., respectively). Our study suggests that, at optimal cetuximab imaging dose, (111) In-cetuximab can be used for visualization of EGFR expression in head-and-neck squamous cell carcinoma using SPECT...
18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome
Bianca A W Hoeben
Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
J Nucl Med 54:532-40. 2013
....